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jjMechanobiology Institute, National University of Singapore, SingaporeABSTRACT EphA2 is a receptor tyrosine kinase (RTK) that is sensitive to spatial and mechanical aspects of the cell’s micro-
environment. Misregulation of EphA2 occurs in many aggressive cancers. Although its juxtacrine signaling geometry (EphA2’s
cognate ligand ephrinA1 is expressed on the surface of an apposing cell) provides a mechanism by which the receptor may
experience extracellular forces, this also renders the system challenging to decode. By depositing living cells on synthetic sup-
ported lipid membranes displaying ephrinA1, we have reconstituted key features of the juxtacrine EphA2-ephrinA1 signaling
system while maintaining the ability to perturb the spatial and mechanical properties of the membrane-cell interface with preci-
sion. In addition, we developed a trans-endocytosis assay to monitor internalization of ephrinA1 from a supported membrane
into the apposing cell using a quantitative three-dimensional fluorescence microscopy assay. Using this experimental platform
to mimic a cell-cell junction, we found that the signaling complex is not efficiently internalized when lateral reorganization at the
membrane-cell contact sites is physically hindered. This suggests that EphA2-ephrinA1 trans-endocytosis is sensitive to the
mechanical properties of a cell’s microenvironment and may have implications in physical aspects of tumor biology.INTRODUCTIONEph receptor signaling plays an important role in many cell
behaviors (1) including vasculogenesis (2,3), axon guidance
(4), and cell migration (5). The 16 Eph receptors constitute
the largest family of receptor tyrosine kinases (RTKs) (6)
and all of them signal in juxtacrine geometry, with the
ligands expressed on an apposing cell membrane. EphB
receptors preferentially bind to transmembrane ephrinB
ligands, whereas the EphA receptors preferentially bind
to glycosylphosphatidylinositol (GPI)-anchored ephrinA
ligands (7). Misregulation of Eph signaling is linked to a
variety of cancers (8,9), with 60–80% of aggressive breast
cancers overexpressing EphA2 (10–15). The mechanisms
by which EphA2 signaling becomes misregulated are
not well understood, due in part to its paradoxical roles:
EphA2 has been shown to both promote and suppress tumor
progression (13,16). For instance, overexpression of non-
mutated EphA2 is sufficient to induce tumorigenesis and
metastasis in nontransformed mammary epithelial cells
(10), and has been associated with poor patient prognosis
(15). Conversely, activation of EphA2 by ephrinA1 attenu-
ates downstream signaling, as measured by phosphorylated
levels of Erk (12) and cell migration (17). Specifically,
EphA2 is in balance between ligand-dependent and
ligand-independent activation (17), and modulating one of
these pathways can significantly alter the overall cellular
response. There is a growing recognition that many aspectsSubmitted October 15, 2013, and accepted for publication March 31, 2014.
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(18,19), and some of the enigmas in EphA2 signaling are
likely a result of different cellular microenvironments.
Mechanical interactions between cells and their microen-
vironment are generally thought to be mediated through
adhesion molecules: integrins, with the extracellular matrix,
and cadherins, with other cells. However, mechanical influ-
ences on signaling are not restricted to adhesion. Micron-
scale spatial organization and mechanical forces applied
to EphA2 were found to alter proximal membrane signaling
events, and the degree and strength of EphA2-ephrinA1
clustering varies systematically across a library of cancer
cell lines in correlation with severity of the disease (20–
22). Thus, physical manipulation of EphA2 alters its
signaling properties and the physical association between
EphA2 receptors differs markedly between diseased and
healthy cells. But precisely how physical forces and spatial
assembly of the EphA2 receptor leads to altered signaling
activity is not well understood.
Endocytosis is another such adhesion-independentmecha-
nochemically regulatedmechanism that in turn can also regu-
late RTK signaling (23–27), either by physically removing
receptors from the cell surface and degrading the proteins
(thereby terminating signaling) or by recycling the receptors
back to the membrane for sustained signaling. Internalized
receptor-ligand complexes that continue signaling from
endosomes can even result in an amplified signal (28). Mis-
regulated endocytic trafficking has been implicated in cancer
and is an attractive target for therapy (26). Eph signal activa-
tion triggers ligand cleavage and shedding from the apposing
cell, which results in deadhesion and repulsion, andhttp://dx.doi.org/10.1016/j.bpj.2014.03.043
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lar details of Eph endocytosis have been discovered (31–
33), although the precise regulation of Eph endocytosis is
not well understood. Modulating endocytosis could directly
alter the balance between ligand-dependent and ligand-inde-
pendent EphA2 signaling in cancer cells (17).
To study the cell-cell contact and how juxtacrine signaling
is regulated by receptor-ligand movement and large-scale
clustering, we have developed a system that interfaces living
cells with supported membranes displaying membrane pro-
teins (Fig. 1 A). A key feature of the supported membrane
is its lateral fluidity (34,35), which allows the ephrinA1
ligands to diffuse freely in two dimensions and coalesce
into large-scale membrane-cell contact regions enriched in
EphA2-ephrinA1, effectively mimicking a cell-cell contact.
Using this experimental platform removes the complexity
of the bidirectional signaling and allows EphA2 forward
signaling triggered by membrane-bound ephrinA1 to be
exclusively studied with high-resolution fluorescence micro-
scopy. Here, we probe the simplified signaling of membrane-
bound ephrinA1. Our assay, however, can easily be adapted
to studymore complex situations of both ephrinA1 paracrine
and juxtacrine signaling by using different fluorescent labels
on the soluble versus the membrane-bound ligands. The
ephrinA1 construct used here lacks a fluorescent fusion pro-
tein (unlike the construct used in (21)) and is biologically
active in solution (Fig. S1 in the Supporting Material),corroborating recent studies showing that secreted ephrinA1
is also able to activate EphA2 (36–38).
Lithographically fabricated patterns on the underlying
glass substrate were used to restrict the microscale diffusion
or transport of lipids and proteins in the supported mem-
brane, while maintaining free lateral mobility within such
corrals (39) (Fig. 1 B). In turn, EphA2 receptors on the sur-
face of a live cell are subjected to these same physical con-
straints when they interact with cognate ephrinA1 ligands in
the corralled supported membrane (20,21,40,41). Fig. 1 C
shows the membrane-cell contact area of breast cancer
cells bound to ephrinA1-containing supported membranes
on glass substrates patterned with differently sized corrals
(1, 3, 5, and 10 mm).
Using this reconstituted juxtacrine signaling platform,
we recently reported that ephrinA1 ligands bound to a
supported membrane are able to trigger EphA2 receptors in
living cells as measured by receptor phosphorylation and
degradation (21). Furthermore, we found that EphA2
signaling responds to the spatial and mechanical properties
of the cell’s microenvironment (20,22). EphA2-ephrinA1
complexes undergo large-scale actomyosin-driven reorga-
nization at the membrane-cell interface, and physical inter-
ference with this movement led to distinct changes in
downstream signaling and cellular behavior. In particular,
we revealed (20) that frustrating EphA2-ephrinA1 micro-
scale lateral movement resulted in a significant decrease inFIGURE 1 Schematic of a cell expressing
EphA2 interacting with a supported membrane dis-
playing ephrinA1. (A) When on a fluid membrane
cells coalesce ephrinA1 into large regions of high
concentration and recruit endocytosis molecules.
(B) When membrane-cell contact sites are physi-
cally perturbed using chromium diffusion barriers,
endocytosis is altered. (C) Bright-field and TIRF
images of ephrinA1 at the interface between the
cell and supported membrane on an unrestrained
substrate and on 10, 5, 3, and 1 mm gridded sub-
strates. Scale bar is 10 mm.
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2198 Greene et al.the recruitment of a disintegrin and metalloprotease 10
(ADAM10). ADAM10 has previously been shown to be
important in trans-cleavage of ephrins upon Eph binding
(42,43), suggesting that ADAM10 activity might be required
for the downregulation of Eph signaling. However, themech-
anisms by which the mechanical features of the cellular
surroundings are translated into these chemical changes,
and how this in turn alters downstream EphA2 signaling,
remain obscure.
Here, we report that these large regions at the membrane-
cell interface that are enriched in EphA2-ephrinA1 recruit
proteins involved in endocytosis (namely clathrin, dynamin,
and ADAM10) at the exclusion of many other molecules
(Fig. 2). This result prompted us to develop a quantitative
single-cell trans-endocytosis assay to probe the effects of
EphA2-ephrinA1 reorganization on ligand endocytosis.
Using this assay, we found that preventing the large-scale
rearrangement and movement of EphA2-ephrinA1 at a
cell-cell interface reduces trans-endocytosis of the ligand.
Furthermore, we found that the receptor-ligand complex is
endocytosed using likely a clathrin mechanism following
ligand cleavage from the apposing cell membrane. These re-
sults provide mechanistic insight into the spatiomechanical
regulation of EphA2 in breast cancer cells.Cl
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Protein expression, purification, and labeling
The soluble, monomeric human ephrinA1 (mEA1) sequence (gift of Hans-
ChristianAsheim,OsloUniversity,Norway)modifiedwith aC-terminal dec-
ahistidine tag (gift of Qian Xu) was cloned into the pFastBac1 (Invitrogen,
Carlsbad, CA) expression cassette. The expression cassette was transformed
into DH10BacEscherichia coli cells (Invitrogen) and DNA was purified to
obtain recombinant viral DNA bacmid. SF9 cells (gift of Ann Fischer, UC
Berkeley, CA) were transfected with the bacmid DNA using Cellfectin II
(Invitrogen) to generate recombinant baculovirus followed by amplification
of viral stocks. SF9 cells were grown in serum-free Sf-900 II SFM insect cell
medium and four liters of mid-logarithmic growth phase cells were infected
with 50 mL of P2 baculovirus. Cells were centrifuged at 6000  g and the
supernatant containing soluble mEA1-H10 was purified using a gravity
flow column containing Ni2þ-NTA agarose (Qiagen, Valencia, CA). The
mEA1-H10 was then covalently labeled with an Alexa Fluor 647 antibody
labeling kit (mEA1-647) per manufacturer’s instructions (Invitrogen).Supported membrane assembly
Vesicles composed of 98 mol % 1,2-dioleoyl-sn-glycero-3-phosphocholine
(DOPC) and 2 mol % of 1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carbox-
ypentyl)iminodiacetic acid) succinyl] (nickel salt) (Ni2þ-NTA-DOGS)
(Avanti Polar Lipids, Alabaster, AL) were made according to standard pro-
cedures (44). Briefly, hydrated lipid vesicles were extruded through a
100 nm membrane 11 times, and then a 30 nm polycarbonate membraneho
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FIGURE 2 Molecular physiology of the EphA2-
ephrinA1 contact sites. The ratio of fluorescence
intensity within and outside regions of ephrinA1
enrichment is a measure of whether the cellular
component is recruited to (values >1) EphA2-
ephrinA1 or excluded from (values<1) those sites;
values near 1 indicate homogeneous distribution
throughout the cell membrane. Clathrin and dyna-
min are colocalized with ephrinA1, caveolin is
antilocalized with ephrinA1, and actin forms a
ring around the large EphA2-ephrinA1 contact
site. Insets are TIRF microscopy images showing
MDAMB231 cells at the membrane-cell interface.
The images are false color overlays of ephrinA1
labeled with Alexa Fluor 647 (magenta) and cell
components expressed as GFP fusions (green).
See Fig. S3 for further details. Scale bar is 10 mm.
EphA2 Spatiomechanics Alters Endocytosis 2199three times using an Avanti Mini-Extruder (Avanti Polar Lipids). Supported
membranes were then formed on #1.5 Warner brand 25 mm round cover-
slips according to standard procedures (44). The supported membrane
was then enclosed in an Attofluor cell chamber (Invitrogen). Membranes
were blocked with 1 mg/mL casein solution before incubating them with
10 nM mEA1-H10 for 1.5 h according to published methods (45). Excess
protein was thoroughly rinsed away and the membranes were then rinsed
with HEPES buffered saline (see below) with 10% fetal bovine serum
(FBS) (Thermo Scientific, Logan, UT) before the addition of cells. (Other
cell media, especially Dulbecco’s modified Eagle’s medium (DMEM) with
10% FBS contained ingredients that significantly interfered with the Ni
chelating of the His-tagged ephrinA1, causing the protein to disconnect
from the membrane within minutes at 37C. In HEPES buffered saline
with 10% FBS, the His-tagged linkage to the membrane was stable for
many hours.)Grid fabrication
Chromium patterns were fabricated on 25 mm diameter round glass cover-
slips, which were etched for 5 min in piranha solution (3:1 H2SO4:H2O2),
and then spin-coated at 1000 rpm with electron-beam resist (ZEP-520A,
Zeon) and conductive polymer (Aquasave, Mitsubishi Rayon). Resist was
exposed via electron-beam lithography (CABL9510CC, Crestec). Patterns
fabricated included four replicate areas each of 1, 3, 5, 10, and 20 mm grids
with line widths of 80 nm. Conductive polymer was removed by rinsing
with deionized water, and then resist was developed for 1 min in isoamyl
acetate. Chromium with thickness of 7 nm was deposited by electron-
beam evaporation (EB3 e-beam evaporator, Edwards). Resist mask was
lifted off by sonicating in methylene chloride for 10 min.Cell culture
MDAMB231 breast-cancer cells (gift of Ann Fischer, UC Berkeley, CA)
were cultured in DMEM with Glutamax (Invitrogen) supplemented with
10% FBS (Thermo Scientific). Cells were stripped from culture flasks
using Cellstripper (Mediatech, Manassas, VA) and resuspended in 1
HEPES buffered saline (20 mM HEPES, 137 mM NaCl, 5 mM KCl,
0.7 mM Na2HPO4$7H2O, 6 mM D-glucose, 1 mM CaCl2$2H2O, 2 mM
MgCl2$6H2O) with 10% FBS for experiments.Immunostaining, inhibitor, and transferrin
experiments
Approximately 300,000 cells were added to each mEA1-647 supported
membrane chamber and allowed to engage the membrane for 45 min in a
cell culture incubator at 37C with 5% CO2. Chambers were then rinsed
with 5 mLs phosphate buffered saline (PBS) followed by cell fixationTABLE 1 DNA constructs used
Construct Vector Fluorescent protein
Human clathrin light chain pN1 N-terminal TagRFP-T
Human dynamin2 pN1 N-terminal EGFP
Human caveolin1 pN1 N-terminal RFP
CD52 GPI anchor pN1 N-terminal EGFP
KRas anchor pN1 N-terminal mCherry
Lck anchor pN1 C-terminal mCherry
RhoA anchor pN1 N-terminal mCherry
PLCd PH domain pC1 C-terminal GFP
Mouse cSrc anchor pN1 C-terminal mCherry Dr. Hec
Mouse cSrc protein pN1 C-terminal mCherry Dr. Hec
Human utrophin pcs2 N-terminal EGFPwith ultrapure 4% paraformaldehyde (Polysciences, Warrington, PA) in
1 PBS for 15 min and finally a 10 mL 1 PBS rinse. For antibody stain-
ing, cells were permeabilized with 0.01% Triton X-100 in 1 PBS for 5 min
and blocked with 1% bovine serum albumin (BSA) in 1 PBS at 4C over-
night. Mouse monoclonal a-ADAM10 primary antibody (Santa Cruz
Biotechnology, Dallas, TX) was added to the cells at a 1:200 dilution in
1% BSA in 1 PBS for 40 min at room temperature. Chambers were rinsed
with 10 mL 1% BSA in 1 PBS and a 1:200 dilution of goat a-mouse sec-
ondary antibodies conjugated to Alexa Fluor 488 (Invitrogen) was added to
the chambers for 20 min at room temperature followed by a 10 mL rinse
with 1 PBS.
To inhibit the clathrin terminal domain, cells were stripped from culture
flasks using Cellstripper (Mediatech) and resuspended in 1 Tris buffered
saline (TBS) with 25 mM Pitstop2 or matching volumes of dimethyl sulph-
oxide (DMSO) control (Abcam, Cambridge, MA) for 10 min in a cell cul-
ture incubator at 37C with 5% CO2. To completely remove the inhibitor,
cells were centrifuged for 3 min at 500  g, washed with 1 TBS, spun
down again, and resuspended in 1 HEPES buffered saline with 10%
FBS before adding to the membrane.
To inhibit ADAM10 and ADAM17, 10 mM INCB003619 (Incyte, Wil-
mington, DE) (or matching volumes of DMSO control) was added to cells
in a culture flask for 24 h. Cells were then stripped from culture flasks using
Cellstripper (Mediatech) and resuspended in 1 HEPES buffered saline
with 10% fetal bovine serum before adding to the membrane.
To monitor transferrin uptake, cells were stripped from culture flasks
using Cellstripper (Mediatech) and resuspended in 1 HEPES buffered
saline with 10% FBS and 25 mg/mL transferrin conjugated to Alexa Fluor
568 (Invitrogen), immediately before adding to the membrane.Transfection reagents
For live-cell imaging experiments, cells were seeded in a 6-well plate, al-
lowed to adhere, and rinsed with 1 Dulbecco’s PBS before changing
the cell medium to low-serum Opti-MEM (Invitrogen). Following manu-
facturer’s instructions, cells were transfected for 5–8 h using 10 mL Lipo-
fectamine 2000 (Invitrogen) and 2.5 mg of the following DNA constructs
(Table 1):Spinning disk confocal and total internal
reflection fluorescence (TIRF) microscopy
All microscopy hardware was controlled with and images were acquired
using Micro-Manager (50). Microscopy was performed on a motorized in-
verted microscope (Nikon Eclipse Ti-E/B, Technical Instruments, Burlin-
game, CA) equipped with a Nikon 100 Apo TIRF 1.49 NA objective
lens, motorized Epi/TIRF illuminator, motorized Intensilight mercury
lamp, Perfect Focus system, and a motorized stage (ASI MS-2000, Eu-
gene, OR). Lasers included the following: 200 mW 488 nm Ar-ion laserSource
Dr. David Drubin, UC Berkeley, CA (46)
Dr. David Drubin, UC Berkeley, CA (46)
Dr. David Drubin, UC Berkeley, CA
Dr. Bjo¨rn Lillemeier and Dr. Mark Davis, Stanford University, CA
Dr. Nick Endres and Dr. John Kuriyan, UC Berkeley, CA
Dr. Hector Huang and Dr. Jay Groves, UC Berkeley, CA (47)
Dr. Hector Huang and Dr. Jay Groves, UC Berkeley, CA (47)
Dr. Tobias Meyer (48), Addgene plasmid 21179
tor Huang and Dr. Jay Groves, UC Berkeley, CA, Addgene plasmid 17685
tor Huang and Dr. Jay Groves, UC Berkeley, CA, Addgene plasmid 17685
Dr. William Bement, University of Wisconsin, WI (49)
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2200 Greene et al.(Spectra Physics 177G, Santa Clara, CA), 100 mW 561 nm optically
pumped solid state laser (Coherent Sapphire, Santa Clara CA), and
100 mW 640 nm diode laser (Coherent Cube, Santa Clara CA). Lasers
were controlled using an acoustooptic tunable filter and aligned into a
dual-fiber launch custom built by Solamere (Salt Lake City, UT): one sin-
gle-mode polarization maintaining fiber (Oz Optics, Ottawa, Canada) was
connected to a TIRF illuminator, whereas the other was connected to the
spinning disk confocal unit.
A spinning disk confocal head was custom fit to the microscope and cam-
era (Yokogawa CSU-X1-M1N-E, Solamere). The dichroic in the spinning
disk head was a T405/488/568/647 multiline (Semrock, Rochester, NY).
Emission filters were the following from Chroma (Bellows Falls, VT)
and in a custom-mounted filter wheel (ASI FW-1000): ET525/50M,
ET605/52M, and ET700/75M. Confocal images were captured using a
1024  1024 pixel electron-multiplying charge-coupled device camera
(Andor iXon3 888, Belfast, Ireland), typically at gain setting 200 and
with pixels binned 2  2 for higher signal/noise. Axial slice step size
was 0.5 mm and extended 20 mm above the coverslip.
TIRF, reflection interference contrast microscopy (RICM), and bright-
field images were collected on an Orca-R2 interline charge-coupled device
camera (Hamamatsu, Hamamatsu, Japan). Dichroics were 2 mm thick and
mounted in metal cubes to preserve optical flatness: ZT488rdc, ZT561rdc,
and ZT640rdc. Long-pass emission filters included: ET500lp, ET575lp, and
ET660lp. Bandpass emission filters were located below the dichroic turret
in a motorized filter wheel (Sutter Lambda 10-3, Novato CA): ET525/50m,
ET600/50m, and ET700/75m. RICM was performed using a 50/50 beams-
plitter with a D546/10 filter. All TIRF filters and dichroics were from
Chroma.
Live-cell imaging was performed using a stage-top incubator and objec-
tive heater (Chamlide TC-A, Quorum Technology, Guelph, Canada).Image analysis
All quantitative image analysis was performed using the ImageJ bundle Fiji
(51). For Fig. 2, intensity ratios were measured for the transfected mole-
cules with ephrinA1 both in and out of ephrinA1-enriched regions. Based
on TIRF and RICM images, ephrinA1-enriched regions and nonephrinA1
regions were identified. Intensities of the transfected molecules at both re-
gions were measured using Fiji, for each type of molecule and an average of
12 cells were analyzed. In each cell, 3 spots in and out of ephrinA1-enriched
regions of each cell were chosen, respectively.
For quantifying ephrinA1 endocytosis, the first few slices of the
confocal stacks were removed, thus eliminating the membrane fluores-
cence and including fluorescence signal only from inside the cell for
further analysis. EphrinA1 punctate spots were automatically identified us-
ing the Fiji analysis function 3D Objects Counter (52), with a threshold set
well above the background (typically three times the average background
pixel value) and minimum and maximum spot sizes to eliminate spurious
pixels or abnormally large fluorescent blobs (e.g., 5–200 pixels). For
several random cells in each sample, mask images outputted from the
3D Objects Counter were visually inspected and compared to the raw
data to ensure that the puncta were adequately quantified (see Movie
S1). For some samples, the raw images were first blurred using a 1 pixel
Gaussian filter before further analysis to increase the accuracy of the auto-
matic object identification.
The Pitstop2-treated cells had slightly dimmer membrane slices on
average compared to DMSO control cells. To ensure that the change in
endocytosis we measured was a result of Pitstop2 treatment and not
due to the amount of ephrinA1 available to the cells, we introduced a sim-
ple correction factor based on the membrane brightness on a cell-by-cell
basis. The correction factor eliminated the already weak correlation
between membrane brightness and number of internal ephrinA1 puncta
(Fig. S2), but did not eliminate the significant difference in endocytosis
for Pitstop2-treated versus control cells. For grid experiments and cells
treated with INCB003619, this correction was not necessary, becauseBiophysical Journal 106(10) 2196–2205we observed no difference in the average brightness of the membrane
slices.
For the three-dimensional (3D) time lapse of the living cell in Fig. 3 and
the cells on grids in Fig. 4, confocal stacks were first blurred using a 1 pixel
Gaussian filter, and then the Interactive Stack Rotation plugin in Fiji was
used to force the voxels to be cubes (the plugin uses linear interpolation
to add extra z slices); the 3D rendering was performed using UCSF Chimera
(53). To normalize the grid plot in Fig. 4 C, the average number of internal
ephrinA1 puncta was rescaled for each sample (which contained multiple
repeats of each grid pattern) so that the value on 20 mm grid pitches (or
off grid for one sample) was unity, so that each sample would be directly
comparable. The actual average value at 20 mm is 4.05 puncta/cell, so
each value in Fig. 4 C was divided by 4.05.
For the radial profile analysis in Fig. S3, the Radial Profile Plot ImageJ
plugin written by Paul Baggethun was used. All plots were created and sta-
tistical tests were run using GraphPad Prism.
Fig. 1, A and B, were created using Protein Data Base (PDB) structures in
Pymol and arranged in Adobe Illustrator. The following PDB files were
used: clathrin triskelion PDB ID: 3IYV (54), EphA2-ephrinA5 PDB ID:
2X11 (55) (note that the structure of the full extracellular domain of
EphA2 in complex with ephrinA1 is not available so this structure was
used instead) and DOPC lipidbook PDB ID: DOPC (56,57).RESULTS
EphA2-ephrinA1 complexes recruit endocytosis
molecules
To provide insight into the components contributing to the
mechanical sensitivity of the EphA2 signaling pathway, we
sought to understand the biomolecular composition of the
large regions of the membrane-cell interface enriched
in EphA2-ephrinA1. To find proteins that colocalize with
EphA2-ephrinA1 complexes, we screened through a library
of candidate signaling molecules using live-cell transfec-
tion of fluorescently tagged proteins. TIRF microscopy was
used to simultaneously visualize ephrinA1 at the mem-
brane-cell interface and the intracellular signaling molecule.
By measuring the fluorescence intensity ratio of the candi-
date molecule to ephrinA1 both inside and outside the
ephrinA1-enriched regions, molecules fell into four distinct
spatial categories: molecules either were homogenously
distributed throughout the cell membrane, or they colocal-
ized with, antilocalized with, or formed a ring around
ephrinA1-enriched regions (Fig. 2 and Fig. S2). Interestingly,
the only molecules found to be enriched at EphA2-ephrinA1
were the endocytosis components clathrin and dynamin, as
well as ADAM10, at the exclusion of many other molecules.
Actin formed a ring around the ephrinA1-enriched regions,
consistent with our previous results that receptor reorganiza-
tion is driven by actomyosin contractility (20). The DiI and
the GPI anchor lipid-associated molecules were found to be
homogenously distributed across the cell membrane. These
localization results indicate that the ephrinA1-enriched re-
gions are sites of clathrin-mediated endocytosis. Therefore,
we hypothesized that the signaling sensitivity to physical
patterning that we previously observed (20) may be related
to endocytosis of the RTK and trans-endocytosis of its ligand
from the juxtaposed membrane.
10 min
30 min
50 min
FIGURE 3 Time-lapse 3D reconstructions of confocal stacks of a single
living MDAMB231 cell as it lands on a supported membrane displaying
ephrinA1. The cell coalesces EphA2-ephrinA1 into large contact regions
at the membrane-cell interface, and then internalizes the receptor and ligand
over time. Only the ephrinA1 protein is fluorescently labeled (with Alexa
Fluor 647), but the images are pseudocolored to encode height above cover-
slip (blue/green for near the coverslip and magenta for > ~1 mm above).
The gray dome approximates the cell outline, which is not fluorescent in
this assay. (See Fig. S4 for a simple grayscale rendering.) An automated ob-
ject-identification program counted the number of puncta within the cells to
measure endocytosis of the EphA2-ephrinA1 complex; only fluorescent
EphA2 Spatiomechanics Alters Endocytosis 2201Trans-endocytosis assay development
To test this hypothesis, we developed a quantitative 3D
fluorescence assay to characterize the trans-endocytosis of
ephrinA1 bound to EphA2. Fluorescently labeled ephrinA1
was imaged inside of breast cancer cells using spinning
disk confocal microscopy. Fig. 3 shows time-lapse 3D
projections of ephrinA1 internalization over 50 min,
demonstrating ephrinA1 endocytosis increasing over time.
Immediately after the single cell landed on the ephrinA1-
containing supported membrane, ephrinA1 was enriched
in regions of contact between the cell and supported mem-
brane as the cell rounds and EphA2 expressed on the sur-
face of the cell bound ephrinA1; those EphA2-ephrinA1
complexes coalesced into large clusters or regions of
high EphA2-ephrinA1 concentration. By 30 and 50 min,
membrane-cell contact sites increased in size and punctate
ephrinA1 spots became visible inside of the cell (see
Movie S2).
Because the only fluorescent molecule in the assay was
ephrinA1, the fluorescence signal inside the cell is a direct
measure of the amount of ligand trans-endocytosed from
the supported membrane. Furthermore, we found that the in-
tensity per ephrinA1 punctate spot is relatively narrowly
distributed (Fig. S5), so we further streamlined the assay
by simply counting the number of ephrinA1 puncta per
cell as a measure of internalized protein. Counting internal
puncta yields similar results to total internal intensity
(Fig. S5), but counting greatly simplifies the analysis,
because it is not necessary to subtract background and
dark counts; therefore, background differences and user-
defined thresholds do not influence the results and the count-
ing analysis is more robust. To automate the process, we
used simple image-analysis software to identify spots in
three dimensions (see Methods). This method provides a
simple and reliable assay for detecting single-cell endocy-
tosis, and it eliminates the high variability inherent in anti-
body staining to quantify internalized signaling molecules.Trans-endocytosis is altered as a function of
EphA2-ephrinA1 spatial reorganization
Using this trans-endocytosis assay, we examined if
ephrinA1 endocytosis is affected by mechanical properties
of the membrane-cell interface. Specifically, we physically
hindered EphA2-ephrinA1 reorganization in breast cancer
cells that highly overexpress EphA2 (20) using patterned
supported membranes containing ephrinA1. After incu-
bating on the membranes for 45 min, cells were fixed and
imaged using spinning disk confocal microscopy and the
amount of ephrinA1 inside each cell was quantified (seespots well above the coverslip and membrane-cell interface (typically 3 mm)
were included in the analysis. For experiments quantifying endocytosis
in hundreds of cells, samples were fixed at 45 min. Scale bar is 10 mm.
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FIGURE 4 Spatiomechanical inhibition of
EphA2-ephrinA1 endocytosis. (A) Fixed
MDAMB231 cells on supported membranes that
are mechanically restricted by 1 mm (left) or 10
mm (right) grids. On small grid pitches, cells gener-
ally exhibited fewer internal ephrinA1 puncta, indi-
cating less endocytosis from the interface. Images
are 3D renderings of confocal fluorescence data of
ephrinA1 labeled using Alexa Fluor 647 (pseudo-
colored as in Fig. 3) and a gray dome approximating
the cell outline. Scale bar is 10 mm. See also Movie
S2. (B) Column scatter graph showing the amount of
internalized ephrinA1 in each cell for one represen-
tative sample, which contained all grid patterns
(e.g., 1, 3, 5, 10, and 20 mm or off grid). Bars
are mean5 standard error of the mean. n>50 cells
on each grid pitch. Note that for 1 and 3 mm,>40%
of the cells contain zero puncta (see Fig. S6). (C)
The result of multiple independent repeats of the
representative sample shown in B. Values were first
normalized to 20mmin each sample, the normalized
values at each grid pitch were then averaged across
all samples. Error bars are standard error of the
mean, n ¼ 6 samples, each with hundreds of cells.
P< 0.05 between 1 and 10mmgrid pitch using ratio
paired t-test.
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2202 Greene et al.Methods). Small corrals inhibited ephrinA1 trans-endocy-
tosis, whereas internalization was successful on unrestricted
substrates (Fig. 4 A and Movie S3, A and B). The number of
punctate ephrinA1 spots inside of cells on substrates with 1,
3, 5, and 10 mm corrals revealed a significant decrease
in the amount of endocytosis on 1 and 3 mm grid sizes
(Fig. 4, B and C). Each cell encountered approximately
the same amount of ephrinA1 protein, indicating that intro-
ducing a spatial and mechanical disruption of EphA2-
ephrinA1 movement regulates trans-endocytosis. As a
control, transferrin uptake in cells encountering patterned
supported membranes with ephrinA1 was also monitored,
and we observed no significant change in the uptake of
transferrin across the different grid sizes (Fig. S7).0.5
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FIGURE 5 Drug inhibition of ephrinA1 trans-endocytosis. (A) Blocking
the clathrin terminal domain with the small molecule Pitstop2 reduces over-
all ephrinA1 endocytosis. Bars are mean5 SE, n ¼ 3 samples each condi-
tion, with >1000 cells per sample. P < 0.05 using the unpaired t-test. (B)
Inhibiting ADAM10 and ADAM17 metalloprotease activity using the small
molecule INCB003619 reduces overall ephrinA1 endocytosis. Bars are
mean5 range, n ¼ 2 samples each condition, with ~1000 cells per sample.
P < 0.05 using the unpaired t-test.Trans-endocytosis of ephrinA1 requires clathrin
and ADAM10
We then asked whether targeted inhibition of the molecules
that colocalize with EphA2-ephrinA1 alters ephrinA1 endo-
cytosis. Cells were treated with the small molecule Pitstop2
to inhibit the clathrin terminal domain (58,59). Treatment
resulted in a significant decrease in ephrinA1 endocytosis,
corroborating that EphA2-ephrinA1 is internalized through
a clathrin-mediated endocytosis mechanism (Fig. 5 A).
These results indicate that EphA2 must be first bound to
ephrinA1, phosphorylated, and then actively internalized,
consistent with recent work using soluble, dimeric eph-
rinA1. Interestingly, the localization of clathrin, dynamin,
and caveolin did not differ dramatically for cells on 1 versus
10 mm gridded substrates (Fig. S8), indicating that EphA2Biophysical Journal 106(10) 2196–2205sensitivity to grids is not simply caused by a change in
recruitment of endocytosis molecules.
Because ADAM10 cleaves ephrinA1 and breaks the me-
chanical linkage to the underlying supported membrane, the
metalloprotease may regulate EphA2-ephrinA1 internaliza-
tion (43). Our prior results indicated that ADAM10 recruit-
ment is significantly reduced in cells on small grids (20), so
we hypothesized that the mechanical sensitivity of EphA2-
ephrinA1 endocytosis may be related to modified ADAM10
EphA2 Spatiomechanics Alters Endocytosis 2203recruitment on grids. We treated cells with the small mole-
cule INCB003619 to inhibit cleavage (60,61) of ephrinA1
by ADAM10 or ADAM17 (Fig. 5 B) and found that inhib-
iting metalloprotease activity significantly reduced the
amount of ephrinA1 inside the cells. This result was consis-
tent with our hypothesis that cleavage of ephrinA1 is
required for efficient internalization of the EphA2-ephrinA1
complex, as well as recent work suggesting that ADAM10 is
required for trans-endocytosis of Eph receptors (43).DISCUSSION
Our results indicate that EphA2 signaling and endocy-
tosis is sensitive to spatial and mechanical properties of
the apposing cell on the scale of microns. Preventing
ephrinA1—and, indirectly, EphA2—from forming large-
scale clusters inhibits endocytosis. This represents a
noncanonical mechanical sensitivity, because the cells are
responding not to adhesion machinery (integrin ligands
are not present in the supported membrane) but instead to
forces directly influencing an RTK (20).
We also found that chemically inhibiting ADAM10 re-
duces trans-endocytosis of ephrinA1. Whether ADAM10
recruitment is the primary regulator of EphA2-ephrinA1
internalization remains to be shown: loss of ADAM10
recruitment to small sites of EphA2-ephrinA1 contact may
be a result of failed endocytosis instead of the cause.
It is possible that cells on physically restrictive substrates
exhibit a systemic shift to a different signaling state, such as
changing from a cell rounding behavior on fluid membranes
to a cell spreading phenotype on gridded substrates, which
would be corroborated by our observation of altered cyto-
skeletal arrangement on gridded substrates (20). However,
our transferrin-uptake results (Fig. S7) indicate that modu-
lating EphA2-ephrinA1 spatial organization does not rede-
fine the entire endocytosis machinery of the cell, even
though transferrin also uses a clathrin-mediated endocytosis
mechanism (62).
Alternatively, clathrin itself may be responding to the me-
chanical properties of EphA2-ephrinA1 contact sites or the
curvature of the cell membrane. A gridded substrate imparts
a pattern on the cell membrane only indirectly, via the cell’s
EphA2 bound to corralled ephrinA1 in the underlying
patterned supported membrane. The smallest grid size
used in this work (1 mm) is sufficiently larger than the
size of a clathrin-coated vesicle (~100 nm) (25,63), but
the small grids result in drastically smaller ephrinA1-
EphA2 clusters (Fig. 1 C). Our colocalization results indi-
cate that clathrin is still recruited on all grid pitches
(Fig. S8), but endocytosis is not as efficient on 1 and 3
mm grids. It is possible that there is a cluster-size threshold
for effective endocytosis.
In addition to the obvious factor of cluster size, ephrinA1
patterning may cause impeded endocytosis in other ways.
Recent work (64) found that clathrin pit maturation maybe impeded by membrane tension. The smaller grid sizes
may introduce far more bending (65) in the cell membrane
or increased tension reducing efficient pit maturation rela-
tive to the larger grid sizes. Furthermore, the cell membrane
should exhibit lower local curvature or undulations when
EphA2-ephrinA1 complexes are allowed to freely coalesce
to large contact sites versus the case where they are corralled
by small grids (66,67). This altered membrane curvature
(24,68), or possibly even impeded flow of cell membrane
lipids (68), may inhibit pit formation or maturation. These
mechanisms remain to be explored.
An argument could be made that our results are simply
due to a decrease in concentration of ephrinA1 on smaller
grid sizes, thereby reducing the amount of material available
to be internalized. For instance, regulation of epidermal
growth factor receptor (EGFR) endocytosis occurs via two
distinct mechanisms, and the balance between the two path-
ways is determined by the ligand concentration (69): at very
high concentrations of the ligand EGF, nonclathrin-medi-
ated endocytosis takes on a larger role (likely because the
clathrin machinery is saturated). However, we do not believe
our findings were the result of such an effect. First, the grids
are barriers to lipid and protein diffusion, but they do not
change the protein concentration; therefore, the number of
ephrinA1 molecules available to a cell is approximately
the same across the different grid sizes. Second, although
we did observe some variability in the brightness under
different cells, that variability did not correlate with grid
pitch. Finally, we found no evidence for significant
concentration dependence: we observed only a very weak
correlation between ephrinA1 concentration and material
internalized (Fig. S2). Instead, the grids primarily disrupt
local concentration (i.e., clustering); therefore, we propose
that endocytosis is strongly influenced by the large-
scale clustering of the RTK-ligand at the membrane-cell
interface.
Here we report a quantitative trans-endocytosis assay of
ligands on a supported membrane, which mimics a cell-
cell junction. These results in conjunction with several
recent findings (20–22,40,70,71), support an emerging
theme in which receptor movement and large-scale clus-
tering during cell-cell contact dramatically alters how
cells signal. This effect ranges from proximal signaling
events, such as recruitment of proteins to the membrane,
to far-downstream signaling events such as endocytosis.
Understanding this regulatory component in greater detail
can provide insight into how receptor movement and reor-
ganization might contribute aberrant signaling in cancer,
especially in tumors that highly overexpress the EphA2
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